Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block vs Oral Drugs for Palmar Hyperhidrosis
NCT06731101Completed
- Sponsor
- Fayoum University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of bupivacaine, lidocaine, dexamethasone, amitriptyline and chlordiazepoxide + clidinium bromide in palmar hyperhidrosis (PH) (2 arms), sponsored by Fayoum University. Primary endpoint: Secretions at 3 months. Started Jan 2025; status: completed.
02
Drugs
bupivacainelidocainedexamethasoneamitriptylinechlordiazepoxide + clidinium bromide
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT06731101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06731101.